The State Drug Administration identified the second batch of 72 key laboratories, such as in-body diagnostic reagent quality research and evaluation

In March 2020, the State Drug Administration carried out the second batch of key laboratory declaration work.
January 2021, the second batch of key laboratory lists will be made public.
February 2021, the State Drug Administration identified and announced the second batch of 72 key laboratories, such as in-body diagnostic reagent quality research and evaluation.
sudden outbreak of coronary pneumonia is a wake-up call to improve the ability to respond to public health emergencies.
, improving the drug regulatory authority's ability to respond to major public health emergencies has become an important consideration in the comprehensive evaluation.
In vitro diagnostic reagent quality research and evaluation key laboratory based on China Food and Drug Inspection Research Institute, in vitro diagnostic reagent quality control key laboratory based on Henan Medical Device Inspection Institute, Beijing Tiantan Hospital affiliated with Capital Medical University, in vitro diagnostic reagent quality evaluation key laboratory based on Beijing Medical Device Inspection Institute, in vitro rapid diagnostic reagent technology transformation and control key laboratory based on China Inspection and Quarantine Science Research Institute, etc.
these key laboratories will provide strong support for drug regulatory authorities to strengthen the research on drug testing techniques for epidemic prevention and control.
2019, the State Drug Administration announced the first batch of 45 key laboratories.
addition to the 72 key laboratories approved this year, the key laboratories of the State Drug Administration have reached 117.
source: NMPA | Editing by Sewer